東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Nanoparticle vaccines by inhalation.

Harvard University.

FindBook

Google Book

Amazon

博客來

Nanoparticle vaccines by inhalation.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nanoparticle vaccines by inhalation./
作者:	Pulliam, Brian Lee.
面頁冊數:	154 p.
附註:	Adviser: David Edwards.
Contained By:	Dissertation Abstracts International70-03B.
標題:	Biophysics, Medical. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3351005
ISBN:	9781109066029

Nanoparticle vaccines by inhalation.
Pulliam, Brian Lee.

Nanoparticle vaccines by inhalation. - 154 p.

Adviser: David Edwards.

Thesis (Ph.D.)--Harvard University, 2009.

Pulmonary vaccination has many potential advantages, however the development of needle-less vaccination for pulmonary delivery may require dry forms of vaccines whose powder properties allow for biocompatibility, low cost, heat and freeze tolerance, efficient aerosolization, and the ability to target cells of the immune system. For each of these reasons nanoparticles can play a critical role in the formulation, development and delivery of needle-less vaccination. The studies presented address the formulation and characterization of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with the CRM-197 and Hepatitis B surface antigens and their evaluation in animals. The work demonstrates how nanoparticles can be created easily using scalable solvent displacement methods and then loaded with antigen at sufficient levels (>5% w/w) for vaccine applications. Under appropriate low temperature conditions, and with a proper mix of excipients, these nanoparticles can be formulated into dry powder aerosols that have excellent safety, aerodynamic, and stability profiles. When administered to the pulmonary tract in animals, these vaccines invoke strong immune responses proving their feasibility as vaccine delivery vehicles. Finally, the approach detailed is extended to other polymer systems such to create novel aerosol forms. These forms open new avenues of engineering and thus represent a major step forward in the development of pulmonary delivery technologies.

ISBN: 9781109066029Subjects--Topical Terms:

1017681
Biophysics, Medical.

Nanoparticle vaccines by inhalation.
LDR:02306nmm 2200265 a 45 001 890592
005 20101103
008 101103s2009 eng d
020 $a 9781109066029
035 $a (UMI)AAI3351005
035 $a AAI3351005
040 $a UMI $c UMI
100 1 $a Pulliam, Brian Lee. $3 1064546
245 1 0 $a Nanoparticle vaccines by inhalation.
300 $a 154 p.
500 $a Adviser: David Edwards.
500 $a Source: Dissertation Abstracts International, Volume: 70-03, Section: B, page: 1540.
502 $a Thesis (Ph.D.)--Harvard University, 2009.
520 $a Pulmonary vaccination has many potential advantages, however the development of needle-less vaccination for pulmonary delivery may require dry forms of vaccines whose powder properties allow for biocompatibility, low cost, heat and freeze tolerance, efficient aerosolization, and the ability to target cells of the immune system. For each of these reasons nanoparticles can play a critical role in the formulation, development and delivery of needle-less vaccination. The studies presented address the formulation and characterization of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with the CRM-197 and Hepatitis B surface antigens and their evaluation in animals. The work demonstrates how nanoparticles can be created easily using scalable solvent displacement methods and then loaded with antigen at sufficient levels (>5% w/w) for vaccine applications. Under appropriate low temperature conditions, and with a proper mix of excipients, these nanoparticles can be formulated into dry powder aerosols that have excellent safety, aerodynamic, and stability profiles. When administered to the pulmonary tract in animals, these vaccines invoke strong immune responses proving their feasibility as vaccine delivery vehicles. Finally, the approach detailed is extended to other polymer systems such to create novel aerosol forms. These forms open new avenues of engineering and thus represent a major step forward in the development of pulmonary delivery technologies.
590 $a School code: 0084.
650 4 $a Biophysics, Medical. $3 1017681
690 $a 0760
710 2 0 $a Harvard University. $3 528741
773 0 $t Dissertation Abstracts International $g 70-03B.
790 $a 0084
790 1 0 $a Edwards, David, $e advisor
791 $a Ph.D.
792 $a 2009
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3351005